Profound Medical (NasdaqCM:PROF) Q4 2025 Earnings call March 05, 2026 04:30 PM ET Company ParticipantsArun Menawat - Chairman and CEOChris Potter - Founder and CEOMathieu Burtnyk - COORashed Dewan - CFOStephen Kilmer - Director of Investor RelationsTom Tamberrino - CCOConference Call ParticipantsBen Haynor - Senior Research AnalystJohn McCauley - Equity Research AnalystMichael Freeman - Equity Research AnalystScott McAuley - Head of Research and Analyst, Healthcare and BiotechnologyOperatorGood day, and tha ...